Bruce McCall

743 total citations
14 papers, 376 citations indexed

About

Bruce McCall is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Bruce McCall has authored 14 papers receiving a total of 376 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 4 papers in Molecular Biology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Bruce McCall's work include Colorectal Cancer Treatments and Studies (5 papers), CAR-T cell therapy research (4 papers) and HER2/EGFR in Cancer Research (4 papers). Bruce McCall is often cited by papers focused on Colorectal Cancer Treatments and Studies (5 papers), CAR-T cell therapy research (4 papers) and HER2/EGFR in Cancer Research (4 papers). Bruce McCall collaborates with scholars based in United States, Spain and Australia. Bruce McCall's co-authors include Maria Anderson, Andrea Pirzkall, Amy V. Kapp, Elicia Penuel, Lori J. Wirth, Antonio Jimeno, Ina Rhee, Chi‐Chung Li, Danny Rischin and Christopher M. Nutting and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Bruce McCall

13 papers receiving 368 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bruce McCall United States 10 276 108 103 95 95 14 376
Bhumsuk Keam South Korea 9 312 1.1× 98 0.9× 134 1.3× 46 0.5× 122 1.3× 17 568
Maria Anderson United States 8 349 1.3× 82 0.8× 115 1.1× 55 0.6× 175 1.8× 10 423
Karen Giselle Chee United States 7 182 0.7× 102 0.9× 163 1.6× 65 0.7× 34 0.4× 9 380
Carla Castanaro United States 6 159 0.6× 245 2.3× 73 0.7× 31 0.3× 102 1.1× 9 434
Yann Bergé France 10 162 0.6× 154 1.4× 100 1.0× 46 0.5× 47 0.5× 17 323
Shinichiro Izawa Japan 9 348 1.3× 82 0.8× 87 0.8× 100 1.1× 255 2.7× 11 476
Noelia Vilariño Spain 12 417 1.5× 98 0.9× 323 3.1× 30 0.3× 74 0.8× 29 593
Maria Bassanelli Italy 10 419 1.5× 99 0.9× 326 3.2× 43 0.5× 57 0.6× 23 547
Aaron J. Schueneman United States 7 183 0.7× 158 1.5× 109 1.1× 36 0.4× 39 0.4× 8 377
Yanjun Hou United States 12 269 1.0× 62 0.6× 67 0.7× 135 1.4× 40 0.4× 29 442

Countries citing papers authored by Bruce McCall

Since Specialization
Citations

This map shows the geographic impact of Bruce McCall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruce McCall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruce McCall more than expected).

Fields of papers citing papers by Bruce McCall

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruce McCall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruce McCall. The network helps show where Bruce McCall may publish in the future.

Co-authorship network of co-authors of Bruce McCall

This figure shows the co-authorship network connecting the top 25 collaborators of Bruce McCall. A scholar is included among the top collaborators of Bruce McCall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruce McCall. Bruce McCall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Komanduri, Krishna V., Anton Belousov, Michelle Byrtek, et al.. (2021). Development of a Predictive Model for Cytokine Release Syndrome to Inform Risk Stratification and CRS Management Following Immunotherapy. Blood. 138(Supplement 1). 1459–1459. 5 indexed citations
2.
Diefenbach, Catherine, Sarit Assouline, Francesc Bosch, et al.. (2019). An Individualized Risk Mitigation Approach for Safety: Experience from the Mosunetuzumab (CD20/CD3 Bispecific Antibody) Development Program in Relation to Neurotoxicity Risk. Blood. 134(Supplement_1). 4728–4728. 3 indexed citations
3.
4.
Weekes, Colin D., Lee S. Rosen, Anna Capasso, et al.. (2018). Phase I study of the anti-α5β1 monoclonal antibody MINT1526A with or without bevacizumab in patients with advanced solid tumors. Cancer Chemotherapy and Pharmacology. 82(2). 339–351. 15 indexed citations
5.
Pawel, Joachim von, David R. Spigel, Thomas J. Ervin, et al.. (2018). Randomized Phase II Trial of Parsatuzumab (Anti-EGFL7) or Placebo in Combination with Carboplatin, Paclitaxel, and Bevacizumab for First-Line Nonsquamous Non-Small Cell Lung Cancer. The Oncologist. 23(6). 654–e58. 19 indexed citations
6.
García‐Carbonero, Rocio, Eric Van Cutsem, Fernando Rivera, et al.. (2017). Randomized Phase II Trial of Parsatuzumab (Anti-EGFL7) or Placebo in Combination with FOLFOX and Bevacizumab for First-Line Metastatic Colorectal Cancer. The Oncologist. 22(4). 375–e30. 23 indexed citations
7.
8.
Fayette, Jérôme, Lori J. Wirth, Cristina Oprean, et al.. (2016). Randomized Phase II Study of Duligotuzumab (MEHD7945A) vs. Cetuximab in Squamous Cell Carcinoma of the Head and Neck (MEHGAN Study). Frontiers in Oncology. 6. 232–232. 84 indexed citations
9.
Infante, Jeffrey R., Aaron R. Hansen, Michael J. Pishvaian, et al.. (2016). A phase Ib dose escalation study of the OX40 agonist MOXR0916 and the PD-L1 inhibitor atezolizumab in patients with advanced solid tumors.. Journal of Clinical Oncology. 34(15_suppl). 101–101. 55 indexed citations
10.
11.
Hill, Andrew, Michael Findlay, Matthew Burge, et al.. (2015). Abstract CT110: Randomized phase II study of duligotuzumab + FOLFIRI versus cetuximab + FOLFIRI in 2nd-line patients with KRAS wild-type (wt) metastatic colorectal cancer (mCRC). Cancer Research. 75(15_Supplement). CT110–CT110. 5 indexed citations
12.
Lafayette, Richard, Bruce McCall, Nicole Li, et al.. (2014). Incidence and Relevance of Proteinuria in Bevacizumab-Treated Patients: Pooled Analysis from Randomized Controlled Trials. American Journal of Nephrology. 40(1). 75–83. 35 indexed citations
13.
Tabernero, Josep, John D. Powderly, Omid Hamid, et al.. (2013). Clinical activity, safety, and biomarkers of MPDL3280A, an engineered PD-L1 antibody in patients with locally advanced or metastatic CRC, gastric cancer (GC), SCCHN, or other tumors.. Journal of Clinical Oncology. 31(15_suppl). 3622–3622. 26 indexed citations
14.
McCall, Bruce, et al.. (1990). Effects of central bolus injections of potassium chloride on arterial potassium concentration in patients undergoing cardiopulmona0ry bypass. Journal of Cardiothoracic Anesthesia. 4(5). 571–576. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bhumsuk Keam Breakdown of academic impact, for papers by Maria Anderson Breakdown of academic impact, for papers by Karen Giselle Chee Breakdown of academic impact, for papers by Carla Castanaro Breakdown of academic impact, for papers by Yann Bergé Breakdown of academic impact, for papers by Shinichiro Izawa Breakdown of academic impact, for papers by Noelia Vilariño Breakdown of academic impact, for papers by Maria Bassanelli Breakdown of academic impact, for papers by Aaron J. Schueneman Breakdown of academic impact, for papers by Yanjun Hou
Rankless by CCL
2026